Fate Therapeutics Inc. (NASDAQ:FATE)
Old Forum Content for FATEMake a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- captron: $FATE - Started a small spec position here. There is a lot written about this biotech company. 2 or 3 drugs in the pipeline for next year.
- WebstreamDyn: $FATE - another bio with a big jump today
debeers: $FATE-Clues you can use. Bought this am here's why:
1.The look at last month- Healthcare in the US was down 1.65%, healthcare in the world down 1.08%, S&P healthcare down .47%. $FATE was UP-3.21%
2. I NEVER ever look at thinly traded stocks. If ...
- petros06: @debeers $FATE Thx for sharing your thought process. It's helpful
- debeers: @petros06 $FATE -you are welcome. PS Boeing will come out of this mr. petros. PS---remember to not leave trash anywhere near the tanker site. Thanks
- JeffyJ: $FATE looks as though some of you guys hopped on
- CHOFF: $FATE - continuing the breakout with a 10% push today
- CHOFF: $FATE - finally breaking out. We'll see if it sticks or rolls over. #CAR-T #CRISPR
- CHOFF: $FATE - posted a while ago on this one. Aggressive buying happening in it the last two days. Resistance at 14.45.
- Sher: @CHOFF $FATE - Interesting company name...
- CHOFF: $FATE - up 14.6% and a big jump in volume today...its NK100 drug showed early signs of efficacy in two patients with ovarian cancer, prompting a price-target upgrade from Wedbush.The company, which now has a $19 price target and an outperform rating, said its Phase 1 Apollo data of NK100 showed the drug was effective. Other Biotechs getting hammered as a group after a strong morning run.
- steve71: @CHOFF $FATE IMHO, a 14% jump based on a 2 patient P1 trial is a SELL. 2 Patients... When I was in med school we had a "friendly" rivalry with Johns Hopkins. One dig was that a Hopkins series of 12 meant 1 patient examined by 12 physicians.
- CHOFF: $CRSP $FATE - added these two Bios to my growth portfolio. I found these via my Minervini Scan. They've been at the top of my scan results for several days. $CRSP reports tomorrow. $FATE reported on the 5th, dropped, and has since resumed trend. Both are up 7%+ today. Keep in mind, they are biotechs...
- CHOFF: @woodman $EDIT $CRSP - just posted on $CRSP and then saw your post below. I too have been watching this one intently. Who knows what happens tomorrow when it reports other then it will be losing money like all the bios. It might follow $FATE 's pattern with a drop and them a trend resumption.
- captron: $FATE - I like the way this chart is shaping up. Anyone ever trade it. Don't see many post on it. It came up on one of my Minervini scans.
- shoredriver: @captron $FATE Earnings Monday....
$FATE Fate Therapeutics... 3.85 8.45%
$CERC Cerecor Inc 3.39 7.96%
$RCMT Rcm Technologies ... 5.00 7.76%
$SQM Sociedad Quimica ... 17.02 7.18%
$CDXS Codexis Inc. 4.50 7.14%
$GLF Gulfmark Offshore... 5.03 6.34%
$SBGL Sibanye Gold Ltd ... 5.89 ...
- judysteiner: $FATE--enters i n deal with JUNO
|Stock Price||$USD 32.43|
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life-threatening diseases.Request Video of FATE
Already a member? Sign in here.
- August 6th, 2020 - 2020 Q2 Earnings
- $USD 23.00 115.17%
- $USD 44.84 88.80%
- $USD 16.54 84.71%
- $USD 5.31 -138.86%
- $USD 12.08 -31.18%
- $USD 5.31 -27.35%
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 70,900 stock analysis videos
- Access an ever expanding library (70,900) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!